This experimental painkiller could be alternative to addictive opioids

ViewAn experimental drug could be a vital player in the plight to end the opioid epidemic.

It's known as VX-548, and its creator, Vertex Pharmaceuticals, said Tuesday the drug's use in late-stage clinical trials resulted in "clinically meaningful reduction in pain," without many of the risks associated with opioids.

In two...